Angela Genge

Angela Genge

Company: QurAlis

Job title: Chief Medical Officer

Seminars:

Panel Discussion: Refining Sensitive Primary Outcome Measures & Navigating Innovative Trial Design in ALS 2:00 pm

Pursuing sensitive markers of disease activity and delineating accurate primary outcome measures beyond ALSFRS-R Driving early diagnosis, patient diversity, and decentralized trial design to establish effective patient recruitment Can we capture statistically meaningful changes in an acute timeframe? Balancing length of trial to demonstrate safety and clinical benefitRead more

day: Day One

Exploring Electrophysiological Biomarkers of Diagnosis & Outcome in ALS 11:00 am

Examining applications of electrophysiology as a biomarker of disease progression Using electrophysiology to track clinical disease progression and efficacy Enhancing repeatability in patients and investigating potential as a primary outcome measureRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.